JP Morgan Healthcare Conference
JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More
Exact Sciences discussed newly released data and its plans for Cologuard, while Luminex provided details about its warning letter from the FDA.
At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market
The firm plans to begin its OTC efforts with a COVID antigen test but also sees potential in migrating other infectious disease tests.
JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More
Qiagen discussed what's in store after a failed bid by Thermo Fisher Scientific, and COVID-19 remained a hot topic on the second day of the virtual conference.
At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing
Last year, the company processed more than 1 million tests, most of them for its reproductive health business, but interest in Prospera and Signatera is growing.Â
Hologic said the acquisition of Biotheranostics will give it a company that operates in markets that are adjacent and complementary to its own.